Literature DB >> 15052250

Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.

John J Mahmarian1, Girish Dwivedi, Tultul Lahiri.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15052250     DOI: 10.1016/j.nuclcard.2003.12.006

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  131 in total

1.  Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location.

Authors:  A A Seals; C M Pratt; J J Mahmarian; S Tadros; N Kleiman; R Roberts; M S Verani
Journal:  Am J Cardiol       Date:  1988-02-01       Impact factor: 2.778

2.  Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3.

Authors:  W J Rogers; J G Canto; C T Lambrew; A J Tiefenbrunn; B Kinkaid; D A Shoultz; P D Frederick; N Every
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

3.  Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes.

Authors:  M D Duca; S Giri; A H Wu; R S Morris; G M Cyr; A Ahlberg; M White; D D Waters; G V Heller
Journal:  J Nucl Cardiol       Date:  1999 Nov-Dec       Impact factor: 5.952

4.  Submaximal predischarge exercise testing after myocardial infarction: prognostic value and limitations.

Authors:  C E Handler
Journal:  Eur Heart J       Date:  1985-06       Impact factor: 29.983

5.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

Authors:  R J Gibbons; D R Holmes; G S Reeder; K R Bailey; M R Hopfenspirger; B J Gersh
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

6.  High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography.

Authors:  J J Mahmarian; L A Moyé; M S Verani; M F Bloom; C M Pratt
Journal:  Am J Cardiol       Date:  1995-06-01       Impact factor: 2.778

Review 7.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

8.  Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

Authors:  M St John Sutton; M A Pfeffer; T Plappert; J L Rouleau; L A Moyé; G R Dagenais; G A Lamas; M Klein; B Sussex; S Goldman
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

9.  Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction.

Authors:  M I Travin; A Dessouki; T Cameron; G V Heller
Journal:  Am J Cardiol       Date:  1995-04-01       Impact factor: 2.778

10.  Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction.

Authors:  A I McGhie; J R Corbett; M S Akers; P Kulkarni; M N Sills; M Kremers; L M Buja; M Durant-Reville; R W Parkey; J T Willerson
Journal:  Am J Cardiol       Date:  1991-02-01       Impact factor: 2.778

View more
  2 in total

1.  The role of stress myocardial perfusion imaging in the risk stratification of patients with remote myocardial infarction.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

2.  Prognostic value of adenosine Tl-201 myocardial perfusion imaging after acute myocardial infarction: results of a prospective clinical trial.

Authors:  Habib A Dakik; Juliet A Wendt; Kay Kimball; Craig M Pratt; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.